Stocktoria

ELI LILLY & Co LLY

NYSE · stock · Pharmaceutical Preparations · website · IPO 1970-07-09

ELI LILLY & Co statistics & valuation

Market cap$1.14T
P / E55.1×
P / S17.5×
P / B42.9×
Dividend yield0.47%
Net margin31.7%
Return on equity77.8%
Net debt$33.6B
Enterprise value USD$1.17T
Graham number -89.9%$123.44

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($123.44); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
12.90% -1.00% 15.00% 37.30% 25.20% 19.70% 21.90% 15.40% 23.50% 31.70% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
19.40% -1.70% 29.60% 308.20% 106.30% 61.00% 58.00% 48.20% 74.20% 77.80% 2016201720182019202020212022202320242025
Shares outstanding
1.06B 1.05B 1.03B 935.7M 912.5M 911.7M 904.6M 903.3M 904.1M 899.3M 2016201720182019202020212022202320242025
Net debt ($)
$4.42B $3.40B $1.88B $11.48B $12.93B $12.92B $12.75B $16.29B $26.21B $33.60B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
7.10% -0.50% 7.40% 21.20% 13.30% 11.40% 12.60% 8.20% 13.50% 18.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
0.64× 0.85× 0.84× 5.12× 2.85× 1.83× 1.37× 1.76× 2.07× 1.54× 2016201720182019202020212022202320242025
EPS ($)
$2.58 -$0.19 $3.13 $8.89 $6.79 $6.12 $6.90 $5.80 $11.71 $22.95 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

ELI LILLY & Co trades at about 53.2× earnings — above its 10-year norm (10-year range 15.7×–111.3×, median 40.1×).

15.7× 111.3×

Shaded band = 10-year range (15.7×–111.3×); dot = today's 53.2×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Net margin31.7%23.5%15.4%21.9%19.7%25.2%37.3%15.0%-1.0%12.9%
Return on assets18.4%13.5%8.2%12.6%11.4%13.3%21.2%7.4%-0.5%7.1%
Return on equity77.8%74.2%48.2%58.0%61.0%106.3%308.2%29.6%-1.7%19.4%
Debt / equity1.54×2.07×1.76×1.37×1.83×2.85×5.12×0.84×0.85×0.64×
Current ratio1.581.150.941.051.231.401.161.731.321.37

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.